Kedrion Biopharma

Kedrion Biopharma stands as a global leader in the biopharmaceutical industry, dedicated to the collection and fractionation of blood plasma. Kedrion Biopharma produces and distributes life-saving plasma-derived therapies worldwide, addressing rare and serious diseases. Kedrion Biopharma is committed to building a healthier future.

Through a strategic alliance with BPL (Bio Products Laboratory) in 2022, Kedrion Biopharma has expanded its reach and expertise, leveraging over 60 years of experience in delivering high-quality plasma-derived medicines. With a presence in over 100 countries and state-of-the-art facilities in Italy, Hungary, the UK, and North America, Kedrion Biopharma continues to strengthen its position as a top player in the field.

Kedrion Biopharma is dedicated to innovation, quality, and patient care. Kedrion Biopharma is building bridges from donors to patients and from plasma to therapies. Kedrion Biopharma welcomes you to explore career opportunities and learn more about our life-saving work. Company information will be completed soon with the support of the company’s management.

We invite the management team at Kedrion Biopharma to create a customized and exclusive company showcase and product listing on our platform.